Suppr超能文献

金属硫蛋白作为DNA流式细胞术的上皮增殖区室标志物。

Metallothionein as an epithelial proliferative compartment marker for DNA flow cytometry.

作者信息

Meskel H H, Cherian M G, Martinez V J, Veinot L A, Frei J V

机构信息

Department of Pathology, University of Western Ontario, London, Canada.

出版信息

Mod Pathol. 1993 Nov;6(6):755-60.

PMID:8302819
Abstract

The antibody to the metal-binding low molecular weight protein metallothionein (MT) stains preferentially the proliferative edge of epithelial tumors in paraffin sections. The present report demonstrates its usefulness as an epithelial cell marker in DNA flow cytometry of archival specimens. Nine control breast (mammoplasty) specimens, 10 control colonic specimens (resection edges), 12 adenocarcinomas of breast, and 13 adenocarcinomas of colon were analyzed by DNA flow cytometry after MT and DNA staining. The average percentage of cells stained by MT ranged from 12% to 27% in these groups of specimens, which contain epithelial as well as stromal and inflammatory cells. Comparing cell turnover, measured as S-phase fraction (SPF) in unstained and MT-stained preparations, it was 10% and 20%, respectively, in control tissues and 10% and 30%, respectively, in adenocarcinomas. The SPF is lower in unstained preparations because of dilution by noncycling inflammatory and stromal cells. Immunohistochemical staining of various tissues for MT showed specific staining of epithelial cells. Evaluation of aneuploid malignant epithelial cells detected in six breast and eight colonic adenocarcinomas showed that on average, 47% of cells were stained with MT and that their SPF increased by about 50% when MT staining was compared with the unstained preparations. The results suggest that MT stains epithelial cells adequately for ploidy and cell cycle evaluation and that it may stain preferentially the proliferating cell compartment, which is considered to be an index of malignancy.

摘要

金属结合性低分子量蛋白质金属硫蛋白(MT)的抗体在石蜡切片中优先标记上皮肿瘤的增殖边缘。本报告证明了其在存档标本的DNA流式细胞术中作为上皮细胞标志物的用途。对9份对照乳腺(乳房成形术)标本、10份对照结肠标本(切除边缘)、12例乳腺腺癌和13例结肠腺癌进行MT和DNA染色后,通过DNA流式细胞术进行分析。在这些包含上皮细胞以及基质和炎症细胞的标本组中,MT染色细胞的平均百分比在12%至27%之间。比较未染色和MT染色制剂中以S期分数(SPF)衡量的细胞更新情况,对照组织中分别为10%和20%,腺癌中分别为10%和30%。由于非循环炎症和基质细胞的稀释,未染色制剂中的SPF较低。对各种组织进行MT免疫组织化学染色显示上皮细胞有特异性染色。对在6例乳腺和8例结肠腺癌中检测到的非整倍体恶性上皮细胞的评估表明,平均而言,47%的细胞被MT染色,与未染色制剂相比,MT染色时它们的SPF增加了约50%。结果表明,MT能充分标记上皮细胞用于倍体和细胞周期评估,并且它可能优先标记增殖细胞区室,而增殖细胞区室被认为是恶性程度的一个指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验